EM · Behavioural and mental health emergencies
Acute agitation and rapid tranquillisation
Also known as Acute agitation · Rapid tranquillisation · Chemical restraint · Severe behavioural disturbance · The agitated patient in the ED · Excited delirium · De-escalation of the agitated patient
Acute agitation in the emergency department — the behavioural emergency defined by motor overactivity, emotional distress and imminent danger to self, staff or others. De-escalation first (verbal, environmental, autonomy-respecting), then the graded pharmacological ladder: oral agents where accepted, then the graded intramuscular pharmacological ladder matched to the cause. Post-administration monitoring (airway, SpO2, BP, ECG for QT). Restraint complications — positional asphyxia, excited-delirium death, rhabdomyolysis, neuroleptic malignant syndrome, torsades de pointes. The organic mimics (hypoxia, hypoglycaemia, sepsis, intracranial, post-ictal, toxidrome) excluded first. Differential of delirium versus psychosis versus intoxication versus withdrawal. ACEM-primary, globally tagged.
Practise this topic
On this page
Related topics
- Mental health and behavioural emergencies
- Consent, capacity and the medico-legal framework in the emergency department
- Alcohol and benzodiazepine withdrawal (emergency department recognition and management)
- The toxidrome approach and the general management of the poisoned patient
- The Mental Health Act and compulsory treatment in the emergency department
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Agitation is organic until a focused assessment proves otherwise — bedside glucose and full vital signs precede any sedative; the patient sedated and restrained for a psychiatric illness that is in fact hypoglycaemia, hypoxia, sepsis or an intracranial bleed is the avoidable death
- Never combine intramuscular olanzapine with a parenteral benzodiazepine — the additive sedation, hypotension and respiratory depression is the classic pharmacological error and is contraindicated by the manufacturer and by Project BETA
- Hyperthermia with agitation is excited delirium until proven otherwise — this is a time-critical medical emergency: active cooling, high-dose benzodiazepine, treat hyperkalaemia and acidosis, and never maintain prone restraint, which is associated with sudden death
- Check the QT before droperidol or haloperidol in any patient with cardiac disease, electrolyte disturbance, a QT-prolonging drug, or a personal or family history of syncope — torsades de pointes is the rare but fatal complication
- Physical restraint is a last resort, time-limited, and released as chemical sedation takes effect — prolonged or prone restraint is associated with rhabdomyolysis, positional asphyxia and sudden death
- Alcohol or benzodiazepine withdrawal is the one agitation where a benzodiazepine is first-line — a dopamine antagonist given alone to a withdrawing patient does not control the withdrawal and risks precipitating delirium tremens
Meet the patient
A 34-year-old man is brought in by police, shouting, posturing at staff, having struck a security officer. The team summons security and reaches for the droperidol. The single step that must happen before the syringe is the bedside glucose — because the agitated, combative patient who is in fact hypoglycaemic, hypoxic, or harbouring an intracranial bleed is the patient who dies sedated and restrained for the wrong diagnosis.[3]
Two questions decide his next ten minutes: is there an organic cause that kills if missed? (the glucose, the observations, the focused neurology, the collateral history) and what is the right agent for the cause? (dopamine antagonist for the psychosis, benzodiazepine for the withdrawal, droperidol for the undifferentiated). Hold those two questions and the ladder slots into place.[1][3]
References16ShowHide
- [1]Richmond JS, Berlin JS, Fishkind AB, Holloman GH Jr, Zeller SL, Wilson MP, Rifai MA, Ng AT. Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup West J Emerg Med, 2012.PMID 22461917
- [2]Wilson MP, Pepper D, Currier GW, et al. The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup West J Emerg Med, 2012.PMID 22461918
- [3]Stowell KR, Florence P, Harman HJ, Glick RL. Psychiatric evaluation of the agitated patient: consensus statement of the american association for emergency psychiatry project Beta psychiatric evaluation workgroup West J Emerg Med, 2012.PMID 22461916
- [4]Ostinelli EG, Brooke-Powney MJ, Li X, et al. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) Cochrane Database Syst Rev, 2017.PMID 28758203
- [5]Cole JB, DeVries PA, O'Flaherty JL, et al. Intramuscular droperidol, olanzapine, midazolam, or lorazepam to treat methamphetamine intoxication in the emergency department Am J Emerg Med, 2026.PMID 41740194
- [6]Casey MF, Elder NM, Fenn A, et al. Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review J Am Geriatr Soc, 2025.PMID 40275439
- [7]Tyr A, Lindeman E, Tamsen F, et al. Incidents of sudden death during restraint of agitated individuals in Sweden between 1992 and 2024 J Forensic Sci, 2026.PMID 41292063
- [8]Baldaçara L, Sanches M, Cordeiro DC, et al. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone Braz J Psychiatry, 2011.PMID 21537720
- [9]Huf G, Alexander J, Gandhi P, Allen MH. Haloperidol plus promethazine for psychosis-induced aggression Cochrane Database Syst Rev, 2016.PMID 27885664
- [10]Isbister GK Droperidol or Olanzapine, Intramuscularly or Intravenously, Monotherapy or Combination Therapy for Sedating Acute Behavioral Disturbance Ann Emerg Med, 2017.PMID 27974168
- [11]Cole JB, Moore JC, Nystrom PC, et al. A prospective study of ketamine versus haloperidol for severe prehospital agitation Clin Toxicol (Phila), 2016.PMID 27102743
- [12]Hernández-Rodríguez L, Bellolio F, Cabrera D, et al. Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients Am J Emerg Med, 2022.PMID 34959024
- [13]Alshehri AM, Crowley KE, Lupi KE, et al. Evaluation of droperidol use in the emergency department: a retrospective analysis of QTc prolongation and adverse events BMC Emerg Med, 2024.PMID 39695417
- [14]Martel ML, Driver BE, Miner JR, et al. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department Acad Emerg Med, 2021.PMID 32888340
- [15]Isoardi KZ, Cole JB, Hoffman RS, Isbister GK. What is the best approach for parenteral sedation to manage severe acute behavioral disturbance in the emergency department? Clin Toxicol (Phila), 2026.PMID 41355751
- [16]Elliott C, Wilson L. The Hennepin Healthcare Forced Ketamine Studies, Excited Delirium, and Police Violence Hastings Cent Rep, 2025.PMID 41091048